Research location
Perth
Western Australia, Australia
Advertisement
Research activity in Perth
Western Australia, AustraliaCureCurrent currently publishes aggregate city-level research activity for this location: 226 trials and 248 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Perth
226 linked trials · page 2 of 5Real-world Treatment Patterns and Associated Outcomes in Patients With Resectable Early-stage Non-small Cell Lung CancerNCT04808050 · 2021-11-03 · 1 site observation
COMPLETED
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTNNCT05198674 · 2021-10-20 · 1 site observation
ACTIVE_NOT_RECRUITING
REducing Sympathetic Activity Through Ultrasound-based Renal deneRvation in Excessive Cardiovascular Risk populaTions.NCT05703620 · 2021-10-08 · 1 site observation
UNKNOWN
Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)NCT04938817 · 2021-08-19 · 1 site observation
ACTIVE_NOT_RECRUITING
64Cu-TLX592 Phase I Safety, PK, Biodistribution and Dosimetry Study (CUPID Study)NCT04726033 · 2021-08-04 · 2 site observations
COMPLETED
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of HypertensionNCT04518293 · 2021-07-09 · 1 site observation
COMPLETED
Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of HypertensionNCT04518306 · 2021-06-14 · 1 site observation
COMPLETED
Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients With HER2-positive Unresectable or Metastatic Breast CancerNCT04857619 · 2021-05-14 · 1 site observation
COMPLETED
Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment TrialNCT04320888 · 2021-05-03 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes MellitusNCT04838405 · 2021-04-29 · 1 site observation
COMPLETED
Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)NCT04776148 · 2021-03-29 · 1 site observation
COMPLETED
Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate CancerNCT04419402 · 2020-08-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)NCT04195555 · 2020-07-20 · 1 site observation
ACTIVE_NOT_RECRUITING
Neuroinflammation in Hypertension StudyNCT04478500 · 2020-07-02 · 1 site observation
UNKNOWN
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)NCT04246177 · 2020-05-22 · 1 site observation
TERMINATED
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)NCT04191096 · 2020-02-12 · 1 site observation
TERMINATED
Statins in Reducing Events in the Elderly (STAREE) Heart Sub-studyNCT04536870 · 2019-12-12 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionNCT03683186 · 2019-09-23 · 1 site observation
ENROLLING_BY_INVITATION
A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain MetastasesNCT03497767 · 2019-08-15 · 1 site observation
COMPLETED
To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET DysregulationNCT04052971 · 2019-08-01 · 1 site observation
COMPLETED
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)NCT03834493 · 2019-07-28 · 1 site observation
TERMINATED
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)NCT03867084 · 2019-05-28 · 1 site observation
COMPLETED
Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) (MK-7902-007/E7080-G000-314/LEAP-007)NCT03829332 · 2019-03-13 · 1 site observation
COMPLETED
Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7080-G000-225/LEAP-004)NCT03776136 · 2019-01-30 · 1 site observation
COMPLETED
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes MellitusNCT03428945 · 2018-08-15 · 1 site observation
TERMINATED
Effects of Sodium-glucose Co-transporter-2( SGLT-2 ) Inhibition on Sympathetic Nervous System Activity in HumansNCT03912909 · 2018-08-01 · 1 site observation
UNKNOWN
A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its SafetyNCT03541174 · 2018-06-18 · 1 site observation
COMPLETED
Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off ReversalNCT03541356 · 2018-05-08 · 1 site observation
COMPLETED
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)NCT03213652 · 2018-04-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Investigate CSL112 in Subjects With Acute Coronary SyndromeNCT03473223 · 2018-03-21 · 1 site observation
COMPLETED
Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade PatientsNCT02922036 · 2018-01-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBCNCT03326674 · 2017-12-21 · 1 site observation
TERMINATED
Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598)NCT03302234 · 2017-12-14 · 1 site observation
COMPLETED
Western Australian Pre-exposure Prophylaxis for HIV Implementation TrialNCT03327155 · 2017-11-16 · 2 site observations
COMPLETED
Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and CisplatinNCT02709512 · 2017-08-01 · 1 site observation
COMPLETED
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)NCT03155620 · 2017-07-31 · 1 site observation
ACTIVE_NOT_RECRUITING
Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic MalignanciesNCT03126110 · 2017-04-25 · 1 site observation
COMPLETED
International Lung Screen Trial (ILST)NCT02871856 · 2017-04-05 · 2 site observations
UNKNOWN
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)NCT03057951 · 2017-03-02 · 1 site observation
COMPLETED
Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMONCT04619303 · 2017-02-07 · 3 site observations
COMPLETED
Breathlessness Exertion and Morphine SulphateNCT02720822 · 2016-08-08 · 1 site observation
COMPLETED
Carvedilol in Preventing Heart Failure in Childhood Cancer SurvivorsNCT02717507 · 2016-04-04 · 2 site observations
COMPLETED
Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent OsteosarcomaNCT02484443 · 2016-02-04 · 1 site observation
COMPLETED
INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)NCT02730338 · 2016-01-01 · 1 site observation
ACTIVE_NOT_RECRUITING
First-In-Human Study Evaluating a Novel Catheter Device in Subjects With Treatment-Resistant HypertensionNCT03314012 · 2015-12-11 · 1 site observation
UNKNOWN
Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLCNCT02504489 · 2015-12-01 · 1 site observation
COMPLETED
Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM)NCT02357147 · 2015-11-03 · 1 site observation
TERMINATED
Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung CancerNCT02481830 · 2015-09-14 · 1 site observation
COMPLETED
An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)NCT02477826 · 2015-08-05 · 1 site observation
COMPLETED
Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.NCT01918215 · 2015-07-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.